Outset Medical (OM) Cash from Investing Activities (2019 - 2026)
Outset Medical (OM) posted quarterly Cash from Investing Activities of $7.9 million for Q1 2026, up 110.12% year-over-year from $3.8 million in Q1 2025, and down 8.04% quarter-over-quarter from $8.6 million in Q4 2025.
Outset Medical (OM) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Cash from Investing Activities for 8 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 110.12% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at -$11.7 million (down 113.79% YoY), while the FY2025 annual figure was -$97.7 million, down 193.98% from the prior year.
- Cash from Investing Activities slipped to $7.9 million in Q1 2026 per OM's latest filing, from $8.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $108.2 million in Q4 2024 and bottomed at -$78.1 million in Q1 2025.
- Historically, Cash from Investing Activities has averaged $1.8 million across 5 years, with a median of $7.9 million in 2026.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 2163.3% — and 2024, when it tumbled 2333.48%.
- Outset Medical's Cash from Investing Activities stood at -$51.7 million in 2022, then soared by 145.27% to $23.4 million in 2023, then jumped by 361.7% to $108.2 million in 2024, then slumped by 92.06% to $8.6 million in 2025, then declined by 8.04% to $7.9 million in 2026.
- Business Quant data shows OM's Cash from Investing Activities at $7.9 million in Q1 2026, $8.6 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.17 Mn |
| Jun 30, 2026 | 14.17 Mn |
| Mar 31, 2026 | 7.90 Mn |
| Mar 31, 2026 | 7.90 Mn |
| Dec 31, 2025 | 8.59 Mn |
| Dec 31, 2025 | 8.59 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | -31.16 Mn |
| Jun 30, 2025 | -31.16 Mn |
| Mar 31, 2025 | -78.08 Mn |
| Mar 31, 2025 | -78.08 Mn |
| Dec 31, 2024 | 108.15 Mn |
| Dec 31, 2024 | 108.15 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Jun 30, 2024 | 38.94 Mn |
| Jun 30, 2024 | 38.94 Mn |
| Mar 31, 2024 | -59.03 Mn |
| Mar 31, 2024 | -59.03 Mn |